» Articles » PMID: 26479700

Evaluating the Stage of Change Model to a Cervical Cancer Screening Intervention Among Ohio Appalachian Women

Overview
Journal Women Health
Publisher Routledge
Date 2015 Oct 20
PMID 26479700
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Cervical cancer incidence and mortality rates are disproportionally high among women living in Appalachia Ohio. This study used the Transtheoretical Model to examine screening barriers before and after a lay health advisor (LHA) intervention (2005-2009) to increase cervical cancer screening rates. Ohio Appalachian women (n = 90) who were in need of a Pap test, based on risk-appropriate guidelines, were randomized to a 10-month LHA intervention and received two in-person visits, two phone calls, and four mailed postcards targeted to the participant's stage of change. Findings revealed that 63% had forward stage movement 10 months after the intervention. The most frequently reported screening barriers were time constraints, forgetting to make an appointment, and cost. Women who reported the following barriers-doctor not recommending the test; being unable to afford the test; and being embarrassed, nervous, or afraid of getting a Pap test-were less likely to be in the action stage. Understanding the stages of change related to Pap testing and reported barriers among this underserved population may help inform researchers and clinicians of this population's readiness for change and how to set realistic intervention goals.

Citing Articles

A Systematic Review of the Effectiveness of Health Education Programs for Cervical Cancer Prevention in Rural Communities: Implications for Promoting Health Equity.

Washington A, Smith L, Anderson G, Randall J, Kayser K, LaJoie S J Cancer Educ. 2023; 39(2):126-138.

PMID: 37996632 PMC: 10994759. DOI: 10.1007/s13187-023-02385-7.


Social determinants of health and US cancer screening interventions: A systematic review.

Korn A, Walsh-Bailey C, Correa-Mendez M, DelNero P, Pilar M, Sandler B CA Cancer J Clin. 2023; 73(5):461-479.

PMID: 37329257 PMC: 10529377. DOI: 10.3322/caac.21801.


Comparative Effectiveness of 2 Interventions to Increase Breast, Cervical, and Colorectal Cancer Screening Among Women in the Rural US: A Randomized Clinical Trial.

Champion V, Paskett E, Stump T, Biederman E, Vachon E, Katz M JAMA Netw Open. 2023; 6(4):e2311004.

PMID: 37115541 PMC: 10148202. DOI: 10.1001/jamanetworkopen.2023.11004.


Understanding of Cervical Screening Adoption among Female University Students Based on the Precaution Adoption Process Model and Health-Belief Model.

Shin H, Kang P, Song S, Jun J Int J Environ Res Public Health. 2023; 20(1).

PMID: 36613020 PMC: 9819152. DOI: 10.3390/ijerph20010700.


Effect of a community-based multicomponent intervention on cervical cancer behavior among women - A randomized controlled trial.

George T, Batra K J Educ Health Promot. 2022; 11:329.

PMID: 36568008 PMC: 9768704. DOI: 10.4103/jehp.jehp_1742_21.


References
1.
Waller J, Bartoszek M, Marlow L, Wardle J . Barriers to cervical cancer screening attendance in England: a population-based survey. J Med Screen. 2010; 16(4):199-204. DOI: 10.1258/jms.2009.009073. View

2.
Holt C, Litaker M, Scarinci I, Debnam K, McDavid C, McNeal S . Spiritually based intervention to increase colorectal cancer screening among African Americans: screening and theory-based outcomes from a randomized trial. Health Educ Behav. 2012; 40(4):458-68. PMC: 5568036. DOI: 10.1177/1090198112459651. View

3.
Russell K, Champion V, Monahan P, Millon-Underwood S, Zhao Q, Spacey N . Randomized trial of a lay health advisor and computer intervention to increase mammography screening in African American women. Cancer Epidemiol Biomarkers Prev. 2010; 19(1):201-10. PMC: 2818428. DOI: 10.1158/1055-9965.EPI-09-0569. View

4.
Norcross J, Krebs P, Prochaska J . Stages of change. J Clin Psychol. 2010; 67(2):143-54. DOI: 10.1002/jclp.20758. View

5.
Marlow L, Waller J, Wardle J . The impact of human papillomavirus information on perceived risk of cervical cancer. Cancer Epidemiol Biomarkers Prev. 2009; 18(2):373-6. PMC: 2674229. DOI: 10.1158/1055-9965.EPI-08-0357. View